Pharming (PHAR) Revenue Growth (3y) (2023 - 2026)
Pharming (PHAR) Revenue Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - | - |
| 10 | Pharming | 8.92 Bn | 8.87 Bn | 65.80 Mn | 19.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.42% |
| Dec 31, 2025 | -99.11% |
| Sep 30, 2025 | 21.54% |
| Jun 30, 2025 | -98.49% |
| Mar 31, 2025 | -98.81% |
| Dec 31, 2024 | 25.99% |
| Sep 30, 2024 | -98.88% |
| Jun 30, 2024 | 37.73% |
| Mar 31, 2024 | -98.92% |
| Dec 31, 2023 | -99.06% |
| Sep 30, 2023 | 7.36% |